Cargando…
Towards the First Biomarker Test for Bipolar Spectrum Disorder: An Evaluation of 199 Patients in an Outpatient Setting
Bipolar spectrum disorder seems to be challenging to diagnose, particularly unspecified or subthreshold types. The delay in diagnosis in the UK for bipolar I and II types is a staggering 10–13 years, with only 15% correctly diagnosed without delay. In the USA, the delay is 6–8 years, and there is a...
Autores principales: | Zamar, Andy, Mohamed, Ashma, Lulsegged, Abbi, Stahl, Daniel, Kouimtsidis, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381128/ https://www.ncbi.nlm.nih.gov/pubmed/37511721 http://dx.doi.org/10.3390/jpm13071108 |
Ejemplares similares
-
A new approach for the treatment of subthreshold bipolar disorders: Targeted high dose levothyroxine and repetitive transcranial magnetic stimulation for mitochondrial treatment
por: Zamar, Andy, et al.
Publicado: (2022) -
A New Treatment Protocol of Combined High-Dose Levothyroxine and Repetitive Transcranial Magnetic Stimulation for the Treatment of Rapid-Cycling Bipolar Spectrum Disorders: A Cohort Evaluation of 55 Patients
por: Zamar, Antonis C., et al.
Publicado: (2022) -
High-dose levothyroxine for the management of bipolar affective disorder: two case reports
por: Zamar, Andy, et al.
Publicado: (2017) -
Bipolar Disorder - New era of Treatments: High dose Levothyroxine, rTMS and genetics
por: Zamar, A., et al.
Publicado: (2022) -
Thyrotoxic Periodic Paralysis: Case Reports and an Up-to-Date Review of the Literature
por: Lulsegged, Abbi, et al.
Publicado: (2011)